Target intelligence / Profile preview

DNA-hydroxyapatite complex (DNA-HAp)

Target
DNA-HAp
Molecular classification
Nucleic acid-mineral complex, Biomaterial interface
01

Overview

DNA adsorbed to hydroxyapatite surfaces refers to a biomolecular-mineral complex rather than a discrete therapeutic target such as a receptor or enzyme. Hydroxyapatite (HAp), the primary inorganic constituent of human bone and teeth, possesses a high affinity for the negatively charged phosphate backbone of DNA, primarily through electrostatic interactions with calcium ions (C-sites) on the crystal surface (Okazaki et al., 2001; ScienceDirect). This interaction is a cornerstone of hydroxyapatite chromatography, a technique used to purify nucleic acids and proteins by exploiting their varying affinities for the mineral surface (Gorbunoff, 1984). In medical research, HAp-DNA complexes are extensively studied as non-viral vectors for gene therapy and bone tissue engineering, where the HAp serves as a biocompatible scaffold that protects DNA from enzymatic degradation and facilitates cellular uptake (Tofighi et al., 2005; Journal of Materials Chemistry). Furthermore, the adsorption of DNA to HAp is critical in forensic science and paleontology, as it explains the long-term preservation of genetic material within skeletal remains (Brundin et al., 2013). Because it describes a physical state or a delivery system rather than a biological molecule whose activity is modulated by drugs, it is not classified as a traditional drug target.

Other names
DNA adsorbed to hydroxyapatite surfacesHydroxyapatite-bound DNADNA-HAp interactionNucleic acid-hydroxyapatite complex
02

Mechanism of action

The complex functions as a delivery vehicle or purification medium where DNA phosphate groups adsorb to calcium sites on the hydroxyapatite surface via electrostatic interactions and coordination bonding (Gorbunoff, 1984; Okazaki et al., 2001).

03

Biological functions

Gene deliveryDNA preservationBiomineralizationChromatographic separation
04

Disease associations

Bone defectsGenetic disordersForensic identification
05

Safety considerations

Biocompatibility of mineral nanoparticlesEfficiency of DNA release from the mineral surfacePotential for localized inflammatory response to HAp particlesStability of the complex in physiological fluids
06

Interacting drugs

Plasmid DNA

3 more in the full profile.

Beyond the preview

Go deeper on DNA-hydroxyapatite complex (DNA-HAp).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA-hydroxyapatite complex (DNA-HAp).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call